Kathleen A. Rickard
Net Worth
Last updated:
What is Kathleen A. Rickard net worth?
The estimated net worth of Dr. Kathleen A. Rickard is at least $286,018,890 as of 25 Nov 2024. He owns shares worth $281,360,274 as insider, has earned $2,490,336 from insider trading and has received compensation worth at least $2,168,280 in Verona Pharma plc.
What is the salary of Kathleen A. Rickard?
Dr. Kathleen A. Rickard salary is $722,760 per year as Chief Medical Officer in Verona Pharma plc.
How old is Kathleen A. Rickard?
Dr. Kathleen A. Rickard is 67 years old, born in 1958.
What stocks does Kathleen A. Rickard currently own?
As insider, Dr. Kathleen A. Rickard owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Verona Pharma plc (VRNA) | Chief Medical Officer | 2,671,480 | $105.32 | $281,360,274 |
What does Verona Pharma plc do?
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. It is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. Verona Pharma plc was incorporated in 2005 and is headquartered in London, the United Kingdom.
Kathleen A. Rickard insider trading
Verona Pharma plc
Dr. Kathleen A. Rickard has made 19 insider trades between 2022-2024, according to the Form 4 filled with the SEC. Most recently he sold 240,000 units of VRNA stock worth $1,176,480 on 25 Nov 2024.
The largest trade he's ever made was exercising 240,000 units of VRNA stock on 25 Nov 2024. As of 25 Nov 2024 he still owns at least 2,671,480 units of VRNA stock.
Verona Pharma key executives
Verona Pharma plc executives and other stock owners filed with the SEC:
- Dr. David S. Zaccardelli (60) Pres, Chief Executive Officer & Executive Director
- Dr. Kathleen A. Rickard (67) Chief Medical Officer
- Mr. Mark W. Hahn (62) Chief Financial Officer